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 To resolve and quantify C3-Epi-25(OH)D from 25(OH)D using LC-MS/MS 
technique.
 Analyse C3-Epi-25(OH)D3/D2 in patient samples received for 25(OH)D 
measurement at the Norfolk and Norwich University Hospital.
LC-MS/MS separations
Assay characteristics
Sample Preparations
1. 100µL of sample/Std/QC.
2. Add 100µL of 0.1M Zinc 
Sulphate.
3. Add 200µL of acetonitrile 
containing internal standards.
Gradient Timetable
Flow rate: 0.4 mL/min
(A)Water : (B)methanol (both 
contains in 0.1% formic acid)
0 – 9.0 min 25% A : 70% B
9.0 – 10.0min 100%B
10.0 – 11.0 min 25% A : 70% B
HPLC Column
Thermo Accucore 2.6µm 100 x 
2.1mm I.D. pentoflurorphenyl solid 
core particle column.
LC-MS/MS system
Micromass Quattro Ultima triple 
quadrupole tandem mass 
spectrometer.
 C3-epi-25OHD3 was found in the majority of our sample cohort, but
prevalence was low.
 C3-epi-25OHD3 contributed to the overestimation of 25OHD3, resulted in
misinterpretation of total vitamin D status.
 High prevalence in infant. Separation of epimer in neonatal samples is
essential.
 DEQAS LC-MS/MS method group using NIST-aligned standards showed a
positive bias against ALTM. NIST assay can resolve C3-epi-25OHD.
 Biological activity and clinical utility of C3-epi-25OHD remains to be
elucidated.
Distribution of C3-epi-25OHD3 concentration in cohort of 
839 adult samples.
Figure 1 showing the structural configuration of the 
hydroxy group at the third carbon (C-3) position.
Figure 2: Chromatograms showing separation of 
C3-epimers from 25OHD.
 LC-MS/MS is currently considered the gold standard method for the measurement of 25OHD. It is able to 
distinguish 25OHD3 from 25OHD2 providing a more accurate assessment of an individuals vitamin D status.
 Interferences from co-eluting isobaric compounds of identical elemental composition but of different structure 
can result in over estimation of total 25OHD.
 C-3 Epimer of 25-hydroxy vitamin D3 and D2 (C3-Epi-25OHD3/D2) differs from 25OHD in configuration of the 
hydroxyl group at the third carbon (C-3) position. It has been shown to be more prevalent in infants and in adults 
with specific disease states.
 Due to the similarity in mass, charge and ionisation characteristics, conventional mass spectrometric systems are 
unable to separate the epimer according to the MRM transitions.
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 C3-epi-25OHD3 detected in 678 out of 839 
(80.9%) of samples.
 C3-epi-25OHD3 ranged between 0.1-45 nmol/L.
 25OHD3 ranged from 1.9 – 156 nmol/L.
 No C3-Epi-25OHD2 detected.
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 4.8% of samples had C3-epi-25OHD3 level 
>10% of 25OHD3. (average 5.1%)
 No correlation was found between C3-epi-
25OHD with 25OHD3.
 5% of samples reinterpreted as vitamin D 
insufficient with C3-epi-25OHD3 is excluded 
from total 25OHD.
Percentage of C3-epi-25OHD3 in relation to 25OHD3.
C3-epi-25OHD3
2H3-C3-epi-25OHD3
2H6-25OHD3
C3-epi-25OHD2
13C2-25OHD2
25OHD3
25OHD2
n  𝒙 SD CV%
Intra-assay
imprecision
10 3.5 0.2 6.6
10 42.4 3.0 7.1
10 64.8 6.4 9.9
Inter-assay 
imprecision
12 3.4 0.2 6.4
12 23.6 2.3 9.7
12 109.9 10.4 9.4
Endogenous C3-Epi-25OHD3
present (nmol/L)
Spiked 
(nmol/L)
Measured value 
(nmol/L) % Recovery
Sample 1 15 50 67 97.0
Sample 2 33.2 50 81 102.7
Sample 3 19.2 100 112 106.4
Sample 4 34.8 100 126 107
Recovery efficiency
Assay imprecision
 Linear calibration from 2.5 –
180nmol/L
 Typical linear regression 
analysis with internal 
standard r2 = 0.995.
 Lower limit of quantification 
(LLOQ): 2.5nmol/L (S:N 10:1).
